Prescient Therapeutics LimitedASX: PTX

Third complete response in PTX-200 AML Trial

Nov 27, 2019 at 4:11 AM UTC · Issued by Prescient Therapeutics Limited

Prescient Therapeutics Ltd has released a press release.

View Attachment